Thomas Hamilton
Fortune : 6 M $ au 31/08/2026
Fortune : 6 M $ au 31/08/2026
Fondateur de la CureFA Foundation, Thomas Edward Hamilton occupe actuellement les postes de président du conseil d'administration de Chondrial Therapeutics, Inc. et de président du conseil d'administration de Chondrial Therapeutics Holdings LLC, ainsi que de président et chef de la direction de Construction Forms, Inc. M. Hamilton est également membre du conseil d'administration d'Annaly Capital Management, Inc. (ancien président), de The Friedreich's Ataxia Research Alliance et de Larimar Therapeutics, Inc. Dans le passé, M. Hamilton a occupé le poste de directeur général chez Citigroup, Inc. et de directeur général chez Salomon Brothers, Inc. (une filiale de Citigroup, Inc.) et de responsable du commerce des produits titrisés chez Barclays Capital, Inc.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/07/2026 | 874 231 ( 1,02 % ) | 3 M $ | 31/08/2026 | |
| 10/06/2026 | 115 000 ( 0,02 % ) | 3 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 28/05/2020 |
| ANNALY CAPITAL MANAGEMENT, INC. | Président | 06/03/2019 |
Construction Forms, Inc.
Construction Forms, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Designs, manufactures and delivers concrete pumping & placing equipment | Directeur/Membre du Conseil | 01/01/2013 |
The Friedreich's Ataxia Research Alliance
The Friedreich's Ataxia Research Alliance Information Technology ServicesTechnology Services Provides patient registry services | Directeur/Membre du Conseil | - |
Chondrial Therapeutics Holdings LLC
Chondrial Therapeutics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Président | - |
| Sociétés | Poste | Fin |
|---|---|---|
Chondrial Therapeutics, Inc.
Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops orphan drugs for mitochondrial diseases | Président | 01/05/2020 |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Trading-Equity | 01/05/2013 |
Salomon Brothers, Inc.
Salomon Brothers, Inc. Investment Banks/BrokersFinance Investment banking services | Corporate Officer/Principal | - |
| CITIGROUP INC. | Corporate Officer/Principal | - |
| ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 11 |
|---|---|
Annaly Capital Management, Inc.
Annaly Capital Management, Inc. Real Estate Investment TrustsFinance Operates as real estate investment trust which invests in residential mortgage-backed securities | Finance |
Citigroup, Inc.
Citigroup, Inc. Major BanksFinance Provides retail, investment, commercial banking, brand cards, securities sale & exchanges services | Finance |
Chondrial Therapeutics, Inc.
Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops orphan drugs for mitochondrial diseases | Health Technology |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Construction Forms, Inc.
Construction Forms, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Designs, manufactures and delivers concrete pumping & placing equipment | Producer Manufacturing |
University of Dayton
University of Dayton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Salomon Brothers, Inc.
Salomon Brothers, Inc. Investment Banks/BrokersFinance Investment banking services | Finance |
The Friedreich's Ataxia Research Alliance
The Friedreich's Ataxia Research Alliance Information Technology ServicesTechnology Services Provides patient registry services | Technology Services |
Chondrial Therapeutics Holdings LLC
Chondrial Therapeutics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
CureFA Foundation | |
Larimar Therapeutics, Inc.
Larimar Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing treatments for complex rare diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national